Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1993 1
1994 3
1995 2
1996 2
1997 5
1998 2
1999 1
2000 6
2001 3
2002 2
2003 2
2004 7
2005 4
2007 3
2008 3
2009 6
2010 5
2011 2
2012 7
2013 4
2014 4
2015 8
2016 8
2017 8
2018 7
2019 10
2020 6
2021 4
2022 19
2023 9
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 22873680

140 results

Results by year

Filters applied: . Clear all
Page 1
Riluzole in augmentation of fluvoxamine for moderate to severe obsessive-compulsive disorder: Randomized, double-blind, placebo-controlled study.
Emamzadehfard S, Kamaloo A, Paydary K, Ahmadipour A, Zeinoddini A, Ghaleiha A, Mohammadinejad P, Zeinoddini A, Akhondzadeh S. Emamzadehfard S, et al. Psychiatry Clin Neurosci. 2016 Aug;70(8):332-41. doi: 10.1111/pcn.12394. Epub 2016 May 26. Psychiatry Clin Neurosci. 2016. PMID: 27106362 Free article. Clinical Trial.
Minocycline combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial.
Esalatmanesh S, Abrishami Z, Zeinoddini A, Rahiminejad F, Sadeghi M, Najarzadegan MR, Shalbafan MR, Akhondzadeh S. Esalatmanesh S, et al. Psychiatry Clin Neurosci. 2016 Nov;70(11):517-526. doi: 10.1111/pcn.12430. Epub 2016 Sep 29. Psychiatry Clin Neurosci. 2016. PMID: 27488081 Free article. Clinical Trial.
Combined fluvoxamine and extended-release methylphenidate improved treatment response compared to fluvoxamine alone in patients with treatment-refractory obsessive-compulsive disorder: A randomized double-blind, placebo-controlled study.
Zheng H, Jia F, Han H, Wang S, Guo G, Quan D, Li G, Huang H. Zheng H, et al. Eur Neuropsychopharmacol. 2019 Mar;29(3):397-404. doi: 10.1016/j.euroneuro.2018.12.010. Epub 2018 Dec 27. Eur Neuropsychopharmacol. 2019. PMID: 30595354 Clinical Trial.
Comparing the efficacy of ondansetron and granisetron augmentation in treatment-resistant obsessive-compulsive disorder: a randomized double-blind placebo-controlled study.
Sharafkhah M, Aghakarim Alamdar M, Massoudifar A, Abdolrazaghnejad A, Ebrahimi-Monfared M, Saber R, Mohammadbeigi A. Sharafkhah M, et al. Int Clin Psychopharmacol. 2019 Sep;34(5):222-233. doi: 10.1097/YIC.0000000000000267. Int Clin Psychopharmacol. 2019. PMID: 31058716 Clinical Trial.
140 results